Marksans Pharma Ltd. News and Updates

Keep track of all breaking news on Marksans Pharma Ltd. from all sources in a single place.

20 Mar 2025

205.58

5.89%

Here's why Marksans Pharma share was buzzing in trade on March 20

Business Standard

The products will be manufactured at the Verna, Goa facility, and will be marketed & distributed in Australian markets through the Marksans Pharma's subsidiary Nova Pharmaceuticals Australasia Pty

Marksans Pharma Ltd. is trading below all available SMAs

Marksans Pharma Ltd.

19 Mar 2025

205.58

5.89%

Marksans Pharma up 3% as arm secures marketing authorisation for Baclofen

Business Standard

The northward move in Marksans Pharma came after the company's wholly-owned subsidiary, Relonchem, received Marketing Authorisation for the product Baclofen 10 mg Tablets from UK MHRA

Marksans Pharma Ltd. has gained 26.24% in the last 1 Year

Marksans Pharma Ltd.

12 Feb 2025

205.58

5.89%

Marksans Pharma Results Earnings Call for Q3FY25

Conference Call with Marksans Pharma Management and Analysts on Q3FY25 Performance and Outlook. Listen to the full earnings transcript.

Marksans Pharma Ltd.

12 Feb 2025

205.58

5.89%

to see Rapid results content

Marksans Pharma Ltd.

26 Nov 2024

205.58

5.89%

Marksans Pharma hits new high; soars 30% in 1 month on healthy Q2 results

Business Standard

The management anticipates stronger performance in the coming quarters due to the company's upcoming new launches, the onset of the winter season and scaling up of the TEVA facility.

Marksans Pharma Ltd. has gained 26.24% in the last 1 Year

Marksans Pharma Ltd.

22 Nov 2024

205.58

5.89%

Marksans Pharma gets USFDA nod for allergic rhinitis treatment tablets

Business Standard

Marksans Pharma Ltd on Friday said it has received final approval from the US health regulator for its generic version of Loratadine tablets indicated in the treatment of allergic rhinitis. The approval by the US Food and Drug Administration (USFDA) is for the company's abbreviated new drug application (ANDA) for Loratadine tablets of strength 10 mg, Marksans Pharma said in a regulatory filing. Loratadine tablets are indicated for the treatment of allergic rhinitis caused by pollen and upper respiratory tract allergy for over-the-counter (OTC) use. This product is a generic version of Clartin tablet in the same strength as Bayer Healthcare, the company added. Loratadine is an antihistamine that treats symptoms such as itching, runny nose, watery eyes, and sneezing from "hay fever" and other allergies, it added.

Marksans Pharma Ltd. has lost -28.90% in the last 6 Months

Marksans Pharma shares climb after USFDA's nod for allergic rhinitis drug

Business Standard | 22 Nov 2024 1 more

Marksans Pharma Ltd.

12 Nov 2024

205.58

5.89%

to see Rapid results content

Marksans Pharma Ltd.

21 Aug 2024

205.58

5.89%

Here's why Marksans Pharma stocks hit 52-week high on August 21; Know more

Business Standard

The surge in the stock price came after the company announced that its wholly owned subsidiary (WOS) Relonchem Limited has secured Marketing Authorisation from UKMHRA for three products.

Marksans Pharma Ltd. is trading below all available SMAs

Marksans Pharma Ltd.

20 Aug 2024

205.58

5.89%

Marksans Pharma hits 52-week high after USFDA issues EIR for Goa facility

Business Standard

Shares of Marksans Pharma soared up to 1.98 per cent at Rs 220.14 per share on the BSE in Tuesday's intraday trade

Marksans Pharma Ltd. has lost -28.90% in the last 6 Months

Marksans Pharma Ltd.

14 Aug 2024, 02:10PM

205.58

5.89%

Marksans Pharma stock zooms 16% to hit record high on strong Q1 results

Business Standard

The US & North America Formulation biz reported growth of 29.8% YoY in Q1FY25, on account of incremental revenue from new product launches, and increase in the share of existing customers.

Marksans Pharma Ltd. has gained 26.24% in the last 1 Year

Marksans Pharma Jumps To Two-Week High After June Quarter Profit Rises

NDTV Profit | 14 Aug 2024, 11:35AM

Is Marksans Pharma Ltd. worth buying?

1384 Votes:

Buy 80.35%

Sell 10.19%

Hold 9.47%

42.69% Fall from 52W High

Marksans Pharma Ltd. News and Updates

Keep track of all breaking news on Marksans Pharma Ltd. from all sources in a single place.